(Q73407350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

1 reference

J Eskola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

19 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

S78-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

Overall cost in the treatment of otitis media

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Carriage of pneumococci after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pneumococcal vaccine and otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Prevention of otitis media in children by pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

Pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900283-8

7 January 2021

10.1016/S0264-410X(00)00283-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163468%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference